ViroStat于1985年，由Douglas McAllister博士创立，致力于为研究者和工业界提供传染性疾病的抗体产品。产品线涵盖病毒学、细菌学和寄生虫学，应用于呼吸道药、性病药、胃肠药/毒素和食源性致病菌的检测。ViroStat拥有超过500种传染性疾病相关的试剂，其中包括MONOTOPE系列单克隆抗体、PMNITOPE多克隆抗体和数量众多的重组蛋白抗原。基于长期的经验积累，ViroStat能够提供从100ug到10g级别的产品。

ViroStat was founded in 1985 by Dr. Douglas McAllister to provide infectious disease antibody tools to researchers and manufacturers. These include the areas of virology, bacteriology and parasitology. Applications for these include detection of respiratory agents, STD agents, gastrointestinal agents/toxins and food borne pathogens.

The company offers more than 500 infectious disease reagents including their MONOTOPE™ monoclonal antibodies, OMNITOPE™ polyclonal antibodies and numerous recombinant antigens. Many of these antibodies are used by manufacturers of rapid, point of care tests currently made and sold in the US.

ViroStat公司产品包括：

MONOTOPE™ - Monoclonal Antibodies (Mouse) 小鼠单克隆抗体

RABMAB® - Monoclonal Antibodies (Rabbit) 兔单克隆抗体

OMNITOPE™ - Polyclonal Antibodies多克隆抗体

RECOMBINANT ANTIGENS 重组抗原

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Zenogen Pharma品牌。

Zenogen Pharma公司主要研发生产治疗性抗体、疫苗佐剂及细胞冻存培养基

（1）治疗性抗体：

通过建立可有效生产特异性抗体和功能性抗体的技术平台，并将其扩展到新药以及其他产品和服务的开发，FZENOGEN公司为创造更好的药物和诊断药物做出了贡献。

（2）疫苗佐剂：

Zenogen Pharma公司开发了一种颗粒聚合物，能够大大增加免疫系统的激活。这种聚合物具有成功提高体液和细胞免疫力的能力，我们发现它具有发挥和安全使用效果的潜力。

（3）细胞冻存培养基：

CELLBANKER是一系列细胞冻存培养基，对于大多数细胞系，该培养基在解冻后可实现80%以上的细胞活力。

STEM-CELLBANKER® GMP grade 细胞冻存液

STEM-CELLBANKER® DMSO Free GMP grade 细胞冻存液

STEM-CELLBANKER® EX GMP grade 细胞冻存液

HSC-BANKER® GMP grade 细胞冻存液

CELLBANKER® 1 细胞冻存液

CELLBANKER® 2 细胞冻存液

CELLOTION® 细胞冻存液

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.